carazolol

This page covers all carazolol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-2 adrenergic receptor, Beta-3 adrenergic receptor, Beta-1 adrenergic receptor.

Targets

Beta-2 adrenergic receptor, Beta-3 adrenergic receptor, Beta-1 adrenergic receptor

Phase 2 pipeline (1)

• Racemic Carazolol · Cardiovascular
  Carazolol works by selectively binding to and blocking the beta-2 adrenergic receptor, which is involved in various physiological responses.

Patent intelligence

• carazolol patent landscape — aggregated cliff calendar, attackable patents, originator estates